tiprankstipranks
Trending News
More News >
Edwards Lifesciences (EW)
NYSE:EW
US Market

Edwards Lifesciences (EW) Ratios

Compare
1,874 Followers

Edwards Lifesciences Ratios

EW's free cash flow for Q4 2024 was $0.79. For the 2024 fiscal year, EW's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.18 3.38 3.03 3.08 3.46
Quick Ratio
3.45 2.40 2.17 2.38 2.56
Cash Ratio
2.02 0.96 0.75 0.84 1.32
Solvency Ratio
1.45 0.59 0.68 0.62 0.36
Operating Cash Flow Ratio
0.36 0.75 1.19 1.68 1.18
Short-Term Operating Cash Flow Coverage
23.18 0.00 47.77 67.93 38.76
Net Current Asset Value
$ 3.29B$ 1.39B$ 610.00M$ 514.00M$ 428.20M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.08 0.08 0.10
Debt-to-Equity Ratio
0.07 0.10 0.12 0.12 0.15
Debt-to-Capital Ratio
0.07 0.09 0.11 0.11 0.13
Long-Term Debt-to-Capital Ratio
0.06 0.08 0.09 0.09 0.12
Financial Leverage Ratio
1.31 1.41 1.43 1.46 1.58
Debt Service Coverage Ratio
36.37 89.14 38.36 38.52 22.81
Interest Coverage Ratio
69.63 87.16 91.07 73.29 103.06
Debt to Market Cap
0.01 0.01 0.01 <0.01 0.01
Interest Debt Per Share
1.20 1.17 1.15 1.14 1.14
Net Debt to EBITDA
-1.36 -0.25 -0.04 -0.09 -0.45
Profitability Margins
Gross Profit Margin
79.46%77.02%79.93%76.13%75.36%
EBIT Margin
28.82%26.91%33.32%33.00%21.41%
EBITDA Margin
31.68%29.44%36.42%36.12%24.49%
Operating Profit Margin
25.35%25.55%32.49%25.77%37.12%
Pretax Profit Margin
28.46%26.61%32.84%32.53%20.90%
Net Profit Margin
76.75%23.35%28.28%28.73%18.77%
Continuous Operations Profit Margin
25.66%23.30%28.28%28.73%18.77%
Net Income Per EBT
269.66%87.75%86.11%88.31%89.82%
EBT Per EBIT
112.29%104.17%101.08%126.21%56.29%
Return on Assets (ROA)
31.98%14.98%18.35%17.68%11.38%
Return on Equity (ROE)
41.75%21.09%26.21%25.76%18.00%
Return on Capital Employed (ROCE)
11.94%18.78%24.05%18.05%25.67%
Return on Invested Capital (ROIC)
10.72%16.40%20.57%15.83%22.86%
Return on Tangible Assets
41.32%18.26%22.24%21.44%14.36%
Earnings Yield
9.43%3.03%3.30%1.86%1.45%
Efficiency Ratios
Receivables Turnover
7.48 7.25 7.70 7.87 7.28
Payables Turnover
5.66 6.85 5.35 6.11 5.50
Inventory Turnover
1.03 1.18 1.23 1.72 1.35
Fixed Asset Turnover
3.05 3.26 3.12 3.19 2.95
Asset Turnover
0.42 0.64 0.65 0.62 0.61
Working Capital Turnover Ratio
1.43 2.44 2.55 2.41 2.05
Cash Conversion Cycle
339.27 306.08 274.98 199.00 254.79
Days of Sales Outstanding
48.81 50.34 47.41 46.38 50.16
Days of Inventory Outstanding
354.94 309.03 295.78 212.38 271.00
Days of Payables Outstanding
64.48 53.28 68.21 59.77 66.37
Operating Cycle
403.75 359.36 343.19 258.76 321.16
Cash Flow Ratios
Operating Cash Flow Per Share
0.91 1.48 1.97 2.78 1.69
Free Cash Flow Per Share
0.49 1.04 1.54 2.25 1.04
CapEx Per Share
0.42 0.44 0.43 0.53 0.65
Free Cash Flow to Operating Cash Flow
0.53 0.70 0.78 0.81 0.61
Dividend Paid and CapEx Coverage Ratio
2.15 3.36 4.60 5.25 2.59
Capital Expenditure Coverage Ratio
2.15 3.36 4.60 5.25 2.59
Operating Cash Flow Coverage Ratio
0.77 1.29 1.76 2.51 1.52
Operating Cash Flow to Sales Ratio
0.10 0.15 0.23 0.33 0.24
Free Cash Flow Yield
0.66%1.36%2.06%1.74%1.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.60 32.99 30.35 53.72 68.98
Price-to-Sales (P/S) Ratio
8.13 7.70 8.58 15.43 12.95
Price-to-Book (P/B) Ratio
4.43 6.96 7.95 13.84 12.42
Price-to-Free Cash Flow (P/FCF) Ratio
152.63 73.49 48.44 57.58 87.79
Price-to-Operating Cash Flow Ratio
81.59 51.64 37.91 46.62 53.87
Price-to-Earnings Growth (PEG) Ratio
0.05 -5.41 14.63 0.65 -3.22
Price-to-Fair Value
4.43 6.96 7.95 13.84 12.42
Enterprise Value Multiple
24.32 25.92 23.52 42.63 52.42
Enterprise Value
EV to EBITDA
24.32 25.92 23.52 42.63 52.42
EV to Sales
7.70 7.63 8.57 15.40 12.84
EV to Free Cash Flow
144.54 72.77 48.36 57.46 87.03
EV to Operating Cash Flow
77.27 51.14 37.85 46.52 53.41
Tangible Book Value Per Share
11.89 8.30 7.04 6.97 4.93
Shareholders’ Equity Per Share
16.73 10.96 9.38 9.36 7.35
Tax and Other Ratios
Effective Tax Rate
0.10 0.12 0.14 0.12 0.10
Revenue Per Share
9.10 9.90 8.70 8.39 7.05
Net Income Per Share
6.98 2.31 2.46 2.41 1.32
Tax Burden
2.70 0.88 0.86 0.88 0.90
Interest Burden
0.99 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.19 0.18 0.18 0.17 0.17
SG&A to Revenue
0.00 0.30 0.29 0.29 0.00
Stock-Based Compensation to Revenue
0.03 0.02 0.02 0.02 0.02
Income Quality
0.13 0.64 0.80 1.15 1.28
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis